Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Sanofi releases its half-year 2026 financial report and updates on business growth and pipeline progress.
SAN
$14.02
+$0.64 +4.78%

Sanofi releases its half-year 2026 financial report and updates on business growth and pipeline progress.

Company Fundamentals
30 Jul 2026
Na
View Source
Bullish
pluang ai news

Sanofi has published its half-year financial report for the period ending June 30, 2026, available on its website and filed with regulatory authorities in France and the US. The report highlights Sanofi's strong business performance, including double-digit sales growth and an upgraded 2026 guidance. Additionally, Sanofi announced the discontinuation of clinical development for amlitelimab in atopic dermatitis, reflecting a strategic pipeline adjustment. These updates demonstrate Sanofi's commitment to innovation and growth in the biopharma sector.

More News (SAN)

Sanofi releases its half-year 2026 financial report and updates on business progress.

Sanofi releases its half-year 2026 financial report and updates on business progress.

Sanofi has published its financial report for the first half of 2026, available on its website and filed with the French financial authority (AMF). The biopharmaceutical company highlights its innovation in R&D and use of AI to drive long-term growth...

Company Fundamentals
Neutral
38 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App